Transcript CHAPTER 11 Haemodialysis Practices

CHAPTER 11
Haemodialysis Practices
Tan Chwee Choon
Shahnaz Shah Firdaus Khan
Rafidah Abdullah
Norleen Bt Zulkarnain Sim
Source: 20th MDTR Report 2012, NRR
Table 11.1.1: Vascular access on haemodialysis,
1997-2012
Access types
Wrist AVF
BCF*
BBF
Graft
HD Catheter
TOTAL
Access types
Wrist AVF
BCF*
BBF
Graft
HD Catheter
TOTAL
Access types
Wrist AVF
BCF*
BBF
Graft
HD Catheter
TOTAL
1997
1998
1999
2000
2001
2002
n
1427
%
85
n
1763
%
84
n
2406
%
81
n
3559
%
82
n
4049
%
79
n
4680
%
78
213
0
17
24
1681
13
0
1
1
100
273
0
26
45
2107
13
0
1
2
100
431
0
42
94
2973
15
0
1
3
100
655
0
42
96
4352
15
0
1
2
100
897
0
83
115
5144
17
0
2
2
100
1068
0
92
181
6021
18
0
2
3
100
2003
n
5249
1359
0
136
240
6984
2004
%
73
21
0
2
4
100
2008
n
9483
4400
70
479
984
15416
n
5891
1693
0
190
332
8106
2005
%
75
20
0
2
3
100
2009
%
62
29
1
3
6
100
n
10665
5243
133
465
1363
17869
n
6405
2169
0
251
484
9309
2006
%
69
23
0
3
5
100
2010
%
60
29
1
3
8
100
n
11130
6105
191
495
1513
19434
n
7798
2856
0
306
640
11600
2007
%
67
25
0
3
6
100
2011
%
57
31
1
3
8
100
n
12569
7360
306
489
1938
22662
n
8309
3421
0
341
843
12914
%
64
27
0
3
7
100
2012
%
56
33
1
2
9
100
n
13574
8741
395
505
2322
25537
%
53
34
2
2
9
100
Source: 20th MDTR Report 2012, NRR
Table 11.1.2: Difficulties report with vascular access, 19972012
Access difficulty
Difficulty with needle placement
Difficulty in obtaining desired blood flow
rate
Other difficulties
No difficulties
TOTAL
Access difficulty
Difficulty with needle placement
Difficulty in obtaining desired blood flow
rate
Other difficulties
No difficulties
TOTAL
Access difficulty
Difficulty with needle placement
Difficulty in obtaining desired blood flow
rate
Other difficulties
No difficulties
TOTAL
1997
1998
1999
2000
2001
2002
n
55
%
47.4
n
82
%
4.2
n
133
%
5.4
n
146
%
3.9
n
217
%
4.5
n
215
%
3.9
48
41.4
60
3.1
112
4.6
136
3.7
239
5
235
4.2
12
1
116
10.3
0.9
100
30
1778
1950
1.5
91.2
100
55
2155
2455
2.2
87.8
100
32
3402
3716
0.9
39
0.8
91.6 4276 89.6
100 4771 100
57
5073
5580
1
90.9
100
2003
2004
2005
2006
2007
n
217
%
3.4
n
255
%
3.3
n
319
%
3.5
n
394
%
3.5
n
478
%
3.8
243
4
301
3.7
354
3.9
356
3.1
368
2.9
60
5970
6490
0.9
91.8
100
67
6957
7580
0.9
92
100
58
8339
9070
0.6
91.9
100
45
10592
11387
0.4
93
100
57
11577
12480
0.5
92.8
100
2008
2009
2010
2011
2012
n
417
%
2.8
n
522
%
3
n
555
%
2.9
n
479
%
2.1
n
635
%
2.5
420
2.8
473
2.7
437
2.3
495
2.2
584
2.3
81
14065
14983
0.5
93.9
100
101
16482
17578
0.6
93.8
100
78
18071
19141
0.4
94.4
100
72
21284
22330
0.3
95.3
100
118
23983
25320
0.5
94.7
100
Source: 20th MDTR Report 2012, NRR
Table 11.1.3: Complications reported with vascular access,
1997-2012
Source: 20th MDTR Report 2012, NRR
Table 11.2.1: Blood flow rates in HD centers, 1997-2012
Blood flow rates
(ml/min)
<150
150-199
200-249
250-299
300-349
>=350
Total
Blood flow rates
(ml/min)
<150
150-199
200-249
250-299
300-349
>=350
Total
Blood flow rates
(ml/min)
<150
150-199
200-249
250-299
300-349
>=350
Total
1997
n
2
34
649
734
176
18
1613
1998
%
0.1
2.1
40.2
45.5
10.9
1.1
100
2003
n
4
84
882
2865
2241
690
6766
%
0.2
1.7
35.5
46.7
14.4
1.4
100
2004
%
0.1
1.1
11.2
39.8
34.7
13
100
2008
n
10
120
928
4630
6126
3094
14908
n
4
36
735
968
298
30
2071
1999
n
11
86
879
3112
2711
1020
7819
%
0.1
1.2
13
42.3
33.1
10.2
100
n
14
126
1178
5050
7093
3977
17438
%
0.2
2.3
33.3
47.4
15.8
1.1
100
n
9
85
1282
1938
812
94
4220
2005
2009
%
0.1
0.8
6.2
31.1
41.1
20.8
100
n
6
65
962
1367
455
31
2886
2000
%
0.1
0.7
6.8
29
40.7
22.8
100
n
7
94
814
3523
3226
1328
8992
%
0.2
2
30.4
45.9
19.2
2.2
100
2006
%
0.1
1
9.1
39.2
35.9
14.8
100
n
5
103
923
3818
4529
1920
11298
2010
n
16
113
1192
5021
7721
4850
18913
2001
%
0.1
0.6
6.3
26.5
40.8
25.6
100
%
0.1
1.4
24.5
44.3
25.4
4.3
100
2007
%
0
0.9
8.2
33.8
40.1
17
100
n
10
87
929
3821
5214
2451
12512
2011
n
14
122
1333
5520
8936
6172
22097
n
7
69
1233
2229
1276
216
5030
%
0.1
0.6
6
25
40.4
27.9
100
%
0.1
0.7
7.4
30.5
41.7
19.6
100
2012
n
15
122
1296
5957
10377
7294
25061
%
0.1
0.5
5.2
23.8
41.4
29.1
100
2002
n
9
69
973
2692
1590
505
5838
%
0.2
1.2
16.7
46.1
27.2
8.7
100
Figure 11.2.1: Blood flow rates in HD centers, 1997-2012
<150 ml/min
150-199 ml/min
200-249 ml/min
250-299 ml/min
300-349 ml/min
>=350 ml/min
50
40
%
30
20
10
0
'97
'98
'99
'00
'01
'02
'03
'04 '05
Year
'06
'07
'08
'09
'10
'11
'12
Source: 20th MDTR Report 2012, NRR
Table 11.2.2: Number of HD sessions per week,
1997-2012
HD sessions
per week
1
2
3
4
Total
HD sessions
per week
1
2
3
4
Total
HD sessions
per week
1
2
3
4
Total
1997
n
1
6
1664
9
1680
1998
%
0.1
0.4
99
0.5
100
2003
n
15
343
6585
9
6952
%
0
0.2
99.6
0.1
100
2004
%
0.1
3.5
96
0.4
100
2008
n
5
259
15043
61
15368
n
1
5
2110
2
2118
n
11
281
7742
30
8064
n
6
269
17574
88
17937
n
4
153
2811
3
2971
n
0.1
5.1
94.6
0.1
100
2005
%
0.2
4.9
94.7
0.1
100
2009
%
0
1.7
97.9
0.4
100
1999
%
0
1.5
98
0.5
100
n
7
265
9010
31
9313
n
8
341
3980
10
4339
%
0.2
7.9
91.7
0.2
100
2006
%
0.1
2.8
96.7
0.3
100
2010
n
9
309
19089
47
19454
2000
%
0
1.6
98.1
0.2
100
n
25
273
11326
34
11658
n
8
337
4761
50
5156
%
0.2
6.5
92.3
1
100
2002
n
10
369
5603
18
6000
%
0.2
6.2
93.4
0.3
100
2007
%
0.2
2.3
97.2
0.3
100
2011
n
6
242
22474
31
22753
2001
%
0
1.1
98.8
0.1
100
n
14
256
12602
31
12903
%
0.1
2
97.7
0.2
100
2012
n
32
351
25247
109
25739
%
0.1
1.4
98.1
0.4
100
Source: 20th MDTR Report 2012, NRR
Table 11.2.3: Duration of HD, 1997-2012
Duration of HD
per session (hours)
<=3
3.5
4
4.5
5
5
TOTAL
Duration of HD
per session (hours)
<=3
3.5
4
4.5
5
>5
TOTAL
Duration of HD
per session (hours)
<=3
3.5
4
4.5
5
>5
TOTAL
1997
n
7
1
1598
67
8
1
1682
1998
%
0.4
0.1
95
4
0.5
0.1
100
2003
n
14
3
6798
66
63
0
6944
%
0.9
0.1
94.4
4.1
0.4
0.1
100
2004
%
0.3
0.1
97.6
1.3
0.6
0
100
2008
n
54
10
15189
74
42
0
15369
n
19
2
1997
87
8
3
2116
1999
n
25
11
7876
106
45
3
8066
%
0.2
0
97.9
1
0.9
0
100
n
66
25
17732
78
42
1
17944
%
0.1
0.3
92.2
5.3
2.1
0
100
n
10
12
4086
154
75
13
4350
2005
2009
%
0.4
0.1
98.8
0.5
0.3
0
100
n
4
9
2738
157
61
0
2969
2000
n
31
9
9174
46
52
0
9312
%
0.3
0.1
98.5
0.5
0.6
0
100
n
77
36
19231
72
50
0
19466
%
0.2
0.3
93.9
3.5
1.7
0.3
100
n
8
12
4988
93
59
0
5160
2006
2010
%
0.4
0.1
98.8
0.4
0.2
0
100
2001
n
28
6
11507
66
42
1
11650
n
71
10
22588
40
39
5
22753
%
0.2
0.2
96.7
1.8
1.1
0
100
n
18
15
5854
60
47
0
5994
2007
%
0.2
0.1
98.8
0.6
0.4
0
100
2011
%
0.4
0.2
98.8
0.4
0.3
0
100
2002
n
37
11
12792
23
31
1
12895
%
0.3
0.1
99.2
0.2
0.2
0
100
2012
%
0.3
0
99.3
0.2
0.2
0
100
n
120
75
25429
72
43
3
25742
%
0.5
0.3
98.8
0.3
0.2
0
100
%
0.3
0.3
97.7
1
0.8
0
100
Table 11.2.4: Dialyser membrane types in HD centres,
1997-2012
Dialyser membrane
Modified Cellulose
Regenerated Cellulose
Hydrophobic/Hypdrophilic
Hydrophilized copolymers
TOTAL
Dialyser membrane
Modified Cellulose
Regenerated Cellulose
Hydrophobic/Hypdrophilic
Hydrophilized copolymers
TOTAL
Dialyser membrane
Modified Cellulose
Regenerated Cellulose
Hydrophobic/Hypdrophilic
Hydrophilized copolymers
TOTAL
1997
n
361
1149
184
1
1695
1998
%
21.3
67.8
10.9
0.1
100
2003
n
1150
1599
3841
35
6625
%
22.1
14.8
62.2
1
100
2008
n
3431
486
10886
286
15089
%
22.7
3.2
72.1
1.9
100
n
413
1201
524
2
2140
1999
%
19.3
56.1
24.5
0.1
100
2004
n
1719
1150
4846
74
7789
%
40.9
33.9
25.2
0
100
2005
%
17.4
24.1
58
0.5
100
2009
n
3241
418
13052
335
17046
n
1224
1017
754
1
2996
2000
n
1974
930
6020
150
9074
%
21.8
10.2
66.3
1.7
100
n
3306
202
13609
409
17526
%
36.7
27.1
36.2
0
100
n
1666
890
1944
0
4500
n
2489
997
7860
161
11507
%
21.6
8.7
68.3
1.4
100
n
3928
60
12005
323
16316
n
1377
1474
2828
1
5680
%
24.2
26
49.8
0
100
2007
2011
%
18.9
1.2
77.7
2.3
100
2002
%
37
19.8
43.2
0
100
2006
2010
%
19
2.5
76.6
2
100
n
1611
1188
1589
0
4388
2001
n
2890
699
8984
137
12710
%
22.7
5.5
70.7
1.1
100
2012
%
24.1
0.4
73.6
2
100
n
3978
10
10970
274
15232
%
26.1
0.1
72
1.8
100
Source: 20th MDTR Report 2012, NRR
Figure 11.2.4: Dialyser membrane types in HD centres,
1997-2012
Modified Cellulose
Hydrophobic/Hypdrophilic
Regenerated Cellulose
Hydrophilized copolymers
100
90
Percent (%)
80
70
60
50
40
30
20
10
0
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
Source: 20th MDTR Report 2012, NRR
Table 11.2.5: Frequency of Dialyser use in HD centres,
1997-2012
Source: 20th MDTR Report 2012, NRR
Table 11.2.6(a): Distribution of prescribed Kt/V, HD patients
1997-2012
Year
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
Number of
patients
1558
2022
2831
4085
4908
5496
6525
7457
8749
11092
12354
14752
17252
18726
21928
24930
Mean
SD
Median
LQ
UQ
% patients ≥ 1.3
1.4
1.4
1.5
1.5
1.5
1.5
1.6
1.6
1.6
1.6
1.6
1.6
1.7
1.6
1.7
1.7
0.3
0.3
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
1.4
1.4
1.5
1.5
1.5
1.5
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.7
1.2
1.2
1.3
1.3
1.3
1.3
1.3
1.4
1.4
1.3
1.3
1.3
1.4
1.4
1.4
1.4
1.6
1.6
1.7
1.7
1.8
1.7
1.8
1.8
1.9
1.8
1.9
1.8
1.9
1.9
1.9
1.9
57
65
73
73
74
73
79
82
81
78
78
80
83
81
83
84
Source: 20th MDTR Report 2012, NRR
Figure 11.2.6(a): Cumulative distribution of prescribed
Kt/V, HD patients 1997-2012
1997
2008
2000
2012
2004
1
.75
.5
.25
0
1
1.2
1.4
1.6
1.8
KT/V
2
2.2
2.4
Source: 20th MDTR Report 2012, NRR
Table 11.2.6(b): Distribution of delivered Kt/V, HD patients
2006-2012
Year
Number of
patients
2006
5555
1.4
1.3
1.4
1.2 1.6
76
60
0.1
2007
6360
1.5
0.6
1.4
1.2 1.6
78
62
0.1
2008
8529
1.4
0.3
1.4
1.2 1.6
78
61
0.1
2009
10467
1.5
0.7
1.4
1.2 1.7
81
65
0.1
2010
11697
1.4
0.5
1.4
1.2 1.6
79
63
0.1
2011
13622
1.5
1.2
1.4
1.2 1.6
80
64
0.1
2012
15800
1.5
0.5
1.5
1.3 1.7
82
67
0.1
Mean SD Median LQ UQ % patients ≥1.2 % patients ≥1.3 Variance*
Source: 20th MDTR Report 2012, NRR
Figure 11.2.6 (b): Cumulative distribution of delivered Kt/V,
HD patients 2006-2012
2006
2010
2008
2012
1
.75
.5
.25
0
.8
1
1.2
1.4
1.6
1.8
2
2.2
KT/V
Source: 20th MDTR Report 2012, NRR
Table 11.2.6(c): Distribution of URR, HD patients
2006-2012
Year
Number of
patients
Mean
SD
Median
LQ
UQ
% patients ≥ 65%
2006
8267
71.4
9.2
71.8
66.3
77.1
79
2007
9945
71.3
9.2
71.9
66.3
77.2
79
2008
12601
71.2
9
71.7
66.2
77
79
2009
14947
71
9
71.7
66.1
76.9
79
2010
16727
71.1
8.6
71.6
66.3
76.8
80
2011
19668
71.1
8.8
71.8
66.1
76.9
79
2012
22837
71
9
71.7
66
77
79
Source: 20th MDTR Report 2012, NRR
Figure 11.2.6 (c): Cumulative distribution of URR, HD
patients 2006-2012
2006
2008
2010
2012
1
.75
.5
.25
0
55
60
65
70
75
80
85
90
URR
Source: 20th MDTR Report 2012, NRR
Table 11.2.7(a): Variation in median blood flow rates in HD
patients, HD centres, 1997-2012
Year
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
Number of
centers
45
46
67
100
116
137
155
184
228
283
302
355
404
435
500
556
Min
200
200
200
200
200
200
200
220
200
200
200
200
180
150
200
165
5th
Centile
200
200
200
200
220
230
240
250
250
250
250
250
250
250
250
250
LQ
Median
UQ
220
230
230
240
250
250
250
257.5
260
270
280
280
280
280
300
300
250
250
250
250
252.5
280
280
287.5
300
300
300
300
300
300
300
300
250
250
250
275
300
300
300
300
300
300
300
300
320
320
330
350
95th
Centile
280
300
300
300
300
300
325
350
350
350
350
350
350
350
350
350
Max
300
300
300
300
350
350
350
400
400
400
400
400
400
400
400
400
Source: 20th MDTR Report 2012, NRR
Figure 11.2.7 (a): Variation in median blood flow rates in
HD patients among centres 2012
Median blood flow rate
(lower quartile, upper quartile)
400
350
300
250
200
150
100
0
50
100
150
200
250 300
Centre
350
400
450
500
550
Source: 20th MDTR Report 2012, NRR
Table 11.2.7 (b) Proportion of patients with blood flow rates
> 300 ml/min, HD centres 1997-2012
Year
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
Number of
centers
45
46
67
100
116
137
155
184
228
283
302
355
404
435
500
556
Min
5th Centile
LQ
Median
UQ
95th Centile
Max
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
5
7
9
11
9
12.5
19
1
2
2
3
8
13
21
23.5
28
30
37
40
42.5
46
55
57
8
11.5
13
14
25.5
33
45
48.5
53
63
68
70
72
75
77
80
19
23
30
38.5
51.5
61
69
73
77
83
84
86
88
90
90
91
43
61
54
69
81
90
91
93
94
94
96
99
99
100
100
100
52
80
100
81
100
100
100
100
100
100
100
100
100
100
100
100
Source: 20th MDTR Report 2012, NRR
Figure 11.2.7 (b): Variation in Proportion of patients with
blood flow rates >= 300 ml/min among HD centres 2012.
% with blood flow rate >=300 ml/min
(lower 95% CI, upper 95% CI)
100
90
80
% patients
70
60
50
40
30
20
10
0
0
50
100
150
200
250 300
Centre
350
400
450
500
550
Source: 20th MDTR Report 2012, NRR
Table 11.2.7 (c): Proportion of patients with 3 HD sessions
per week, HD centres 1997-2012
Year
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
Number of
centers
47
46
69
100
118
137
160
188
231
287
309
358
404
437
502
562
Min
80
80
17
25
23
28
36
37
40
52
51
51
18
20
50
17
5th
Centile
92
98
45
44.5
50
48
55
70
75
83
87
89
88
90
93
90
LQ
Median
UQ
95th Centile
Max
99
100
97
90.5
92
94
97
98
99
98
98
98
100
100
100
98
100
100
100
100
100
99
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
Source: 20th MDTR Report 2012, NRR
Figure 11.2.7 (c): Variation in proportion of patients with 3
HD sessions per week among HD centres 2012
% with 3 HD sessions per week
(lower 95% CI, upper 95% CI)
100
90
80
% patients
70
60
50
40
30
20
10
0
0
50
100
150
200
250 300
Centre
350
400
450
500
550
Source: 20th MDTR Report 2012, NRR
Table 11.2.7 (d): Median prescribed Kt/V in HD patients,
HD centres 1997-2012
Year
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
Number of
centers
44
45
67
99
114
132
150
181
224
281
302
353
400
434
500
555
Min
1.2
1
1.1
1
1.2
1.2
1.1
1.2
1.2
1
1.1
1.1
1.1
0.8
1.1
1.1
5th
Centile
1.2
1.3
1.3
1.3
1.3
1.3
1.3
1.4
1.3
1.3
1.3
1.3
1.3
1.3
1.3
1.4
LQ
Median
UQ
1.3
1.3
1.4
1.4
1.4
1.4
1.4
1.5
1.5
1.4
1.4
1.5
1.5
1.5
1.5
1.5
1.4
1.4
1.5
1.5
1.5
1.5
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.4
1.5
1.6
1.6
1.6
1.6
1.7
1.7
1.7
1.7
1.7
1.7
1.7
1.7
1.8
1.8
95th
Centile
1.5
1.5
1.8
1.8
1.7
1.7
1.9
1.9
1.8
1.8
1.8
1.9
1.9
1.9
2
2
Max
1.7
1.6
1.8
2.8
1.9
1.8
2
2.2
2
2.1
2.2
2.1
2.2
2.9
2.5
2.8
Source: 20th MDTR Report 2012, NRR
Figure 11.2.7 (d): Variation in median prescribed Kt/V in
HD patients among HD centres 2012
Median prescribed KT/V
(lower quartile, upper quartile)
3.5
3
KT/V
2.5
2
1.5
1
0
50
100
150
200
250 300
Centre
350
400
450
500
550
Source: 20th MDTR Report 2012, NRR
Table 11.2.7 (e): Proportion of patients with prescribed Kt/V
≥ 1.3, 1997-2012
Year
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
Number of
centers
44
45
67
99
114
132
150
181
224
281
302
353
400
434
500
555
Min
32
0
29
26
33
26
30
28
32
0
21
14
26
6
15
29
5th
Centile
42
42
45
43
42
43
48
58
58
46
50
48
53.5
50
57
58
LQ
Median
UQ
50
57
65
64
67
65
71
74
73
68
67
69
75
74
76
77
60
67
73
79
75
74.5
81
83
82
80
80
83
85
85
86
86
69
73
84
84
84
83
89
91
90.5
88
89
90
92
91
93
93
95th
Centile
80
83
94
94
93
92
96
98
98
96
96
98
97.5
100
100
100
Max
91
88
100
100
100
98
100
100
100
100
100
100
100
100
100
100
Source: 20th MDTR Report 2012, NRR
Figure 11.2.7 (e): Variation in proportion of patients with
prescribed Kt/V ≥ 1.3 among HD centres 2012
% with prescribed KT/V >=1.3
(lower 95% CI, upper 95% CI)
100
90
80
% patients
70
60
50
40
30
20
10
0
0
50
100
150
200
250 300
Centre
350
400
450
500
550
Source: 20th MDTR Report 2012, NRR
Table 11.2.7 (f): Median delivered Kt/V in HD patients, HD
centres 2006-2012
Year
Number of
centers
2006
142
1
2007
157
2008
Min 5th Centile
95th Centile Max
LQ
Median
UQ
1.2
1.3
1.4
1.5
1.6
1.7
1.1
1.2
1.3
1.4
1.5
1.7
1.8
199
1
1.2
1.3
1.4
1.5
1.7
1.8
2009
239
1
1.2
1.3
1.4
1.5
1.6
2
2010
253
0.8
1.1
1.3
1.4
1.5
1.6
2
2011
302
0.9
1.2
1.3
1.4
1.5
1.7
2
2012
355
1
1.2
1.3
1.5
1.5
1.7
2.2
Source: 20th MDTR Report 2012, NRR
Figure 11.2.7 (f): Variation in median delivered Kt/V in HD
patients among HD centres 2012
Median delivered KT/V
(lower quartile, upper quartile)
2.4
2.2
2
KT/V
1.8
1.6
1.4
1.2
1
.8
.6
0
30
60
90
120
150
180 210
Centre
240
270
300
330
360
Source: 20th MDTR Report 2012, NRR
Table 11.2.7 (g): Proportion of patients with delivered Kt/V
≥ 1.2, HD centres 2006-2012
Year
Number of
centers
2006
142
0
2007
157
2008
Min 5th Centile
95th Centile Max
LQ
Median
UQ
43
65
76.5
86
94
100
34
46
70
79
89
98
100
199
21
49
68
81
89
100
100
2009
239
18
51
74
84
90
97
100
2010
253
0
47
71
83
89
98
100
2011
302
6
51
73
84
91
100
100
2012
355
26
49
74
85
92
98
100
Source: 20th MDTR Report 2012, NRR
Figure 11.2.7 (g): Variation in proportion of patients with
delivered Kt/V ≥ 1.2, HD centres 2012
% with delivered KT/V >=1.2
(lower 95% CI, upper 95% CI)
100
90
80
% patients
70
60
50
40
30
20
10
0
0
30
60
90
120
150
180 210
Centre
240
270
300
330
360
Source: 20th MDTR Report 2012, NRR
Table 11.2.7 (h): Median URR among HD patients, HD
centres 2006-2012
Year
Number of
centers
Min
5th Centile
LQ
Median
UQ
95th Centile
Max
2006
214
55.4
64.2
68.9
71.5
74.3
78.2
94.4
2007
245
56.1
65.3
69.6
71.8
74.8
78
95.5
2008
310
40.4
63.5
68.5
71.6
74.4
77.9
93.6
2009
350
60
64.4
68.7
71.8
74.1
77
93.3
2010
397
54.6
64.8
69
71.3
73.8
76.7
94
2011
464
45.2
64.6
68.8
71.7
74.3
77.9
96.8
2012
525
56.3
65.1
68.6
71.7
74
77.5
96
Source: 20th MDTR Report 2012, NRR
Figure 11.2.7 (h): Variation in median URR among HD
patients, HD centres 2012
Median URR
(lower quartile, upper quartile)
100
90
URR %
80
70
60
50
40
0
50
100
150
200
250 300
Centre
350
400
450
500
Source: 20th MDTR Report 2012, NRR
Table 11.2.7 (i): Proportion of HD patients with URR ≥
65%, HD centres 2006-2012
Year
Number of
centers
Min
5th Centile
LQ
Median
UQ
95th Centile
Max
2006
214
0
50
69
79.5
88
97
100
2007
245
15
51
71
82
89
97
100
2008
310
0
43
69
82.5
90
98
100
2009
350
22
45
69
81
89
97
100
2010
397
13
48
69
82
90
98
100
2011
464
0
49
69
82
90
100
100
2012
526
17
50
68
80
89
98
100
Source: 20th MDTR Report 2012, NRR
Figure 11.2.7 (i): Variation in proportion of patients with
URR ≥ 65% among HD centres 2012
% with URR >=65%
(lower 95% CI, upper 95% CI)
100
90
80
% patients
70
60
50
40
30
20
10
0
0
50
100
150
200
250 300
Centre
350
400
450
500
Source: 20th MDTR Report 2012, NRR
Table 11.3.1(a): Unadjusted technique survival by year of entry, 1993-2012
Source: 20th MDTR Report 2012, NRR
Figure 11.3.1(a): Unadjusted technique survival by year of
entry, 1993-2012
Kaplan-Meier survival estimates, by Year
1.00
Yr 2012
Yr 2010
0.75
Yr 2008
Yr 2006
Yr 2004
Yr 2002
0.50
Yr 2000
Yr 1998
Yr 1996
Yr 1994
0.25
0.00
0
24
48
72
96
120 144
Duration in months
168
192
216
240
Source: 20th MDTR Report 2012, NRR
Table 11.3.1(b): Unadjusted technique survival by year of entry (censored for
death & transplant), 1993-2012
Source: 20th MDTR Report 2012, NRR
Figure 11.3.1(b): Unadjusted technique survival by year of
entry (censored for death & transplant), 1997-2012
Kaplan-Meier survival estimates, by Year
1.00
Yr '12
Yr '10
Yr '08
Yr '06
Yr '04
Yr '02
Yr '00
Yr '98
Yr '96
Yr '94
0.75
0.50
0.25
0.00
0
24
48
72
96
120 144
Duration in months
168
192
216
240
Source: 20th MDTR Report 2012, NRR
Table 11.3.2(a): Unadjusted technique survival by age,
1993-2012
Source: 20th MDTR Report 2012, NRR
Figure 11.3.2(a): Unadjusted technique survival by age,
1997-2012
Kaplan-Meier survival estimates, by Age
1.00
0.75
Age 15-24
Age 25-34
Age 1-14
0.50
Age 35-44
Age 45-54
0.25
Age 55-64
Age>=65
0.00
0
24
48
72
96
120 144
Duration in months
168
192
216
240
Source: 20th MDTR Report 2012, NRR
Table 11.3.2(b): Unadjusted technique survival by age
(censored for death & transplant), 1993-2012
Source: 20th MDTR Report 2012, NRR
Figure 11.3.2(b): Unadjusted technique survival by age
(censored for death & transplant), 1997-2012
Kaplan-Meier survival estimates, by Age
1.00
Age 1-14
Age 15-24
Age 25-34
Age 35-44
Age 45-54
Age 55-64
Age>=65
0.75
0.50
0.25
0.00
0
24
48
72
96
120 144
Duration in months
168
192
216
240
Source: 20th MDTR Report 2012, NRR
Table 11.3.3(a): Unadjusted technique survival by diabetes
status, 1993-2012
Diabetes
status
Interval
(month)
0
6
12
n
% Survival
23246
20715
18551
24
36
48
60
72
84
96
108
120
Non-Diabetic
Diabetic
SE
n
% Survival
SE
100
94
90
0
0
27980
24566
21160
100
93
86
0
0
14966
12264
10037
8174
83
77
72
66
0
0
0
0
15567
11343
8032
5649
73
62
52
44
0
0
0
0
6639
5330
4284
3417
2712
61
56
52
48
44
0
0
0
0
0
3859
2501
1623
1010
640
36
29
24
19
15
0
0
0
0
0
Source: 20th MDTR Report 2012, NRR
Figure 11.3.3(a): Unadjusted technique survival by
diabetes status, 1993-2012
Kaplan-Meier survival estimates, by Diabetes
1.00
0.75
Non-diabetic
0.50
0.25
Diabetic
0.00
0
24
48
72
96
120 144
Duration in months
168
192
216
240
Source: 20th MDTR Report 2012, NRR
Table 11.3.3(b): Unadjusted technique survival by diabetes
status (censored for death & transplant), 1993-2012
Diabetes status
Interval
(month)
0
6
12
24
Non-Diabetic
n
% Survival
23246
20715
18551
14966
36
48
60
72
84
96
108
120
Diabetic
SE
n
% Survival
SE
100
99
99
99
0
0
0
27980
24566
21160
15567
100
100
99
99
0
0
0
12264
10037
8174
6639
98
98
97
97
0
0
0
0
11343
8032
5649
3859
98
97
97
96
0
0
0
0
5330
4284
3417
2712
97
96
96
95
0
0
0
0
2501
1623
1010
640
96
96
95
94
0
0
0
0
Source: 20th MDTR Report 2012, NRR
Figure 11.3.3(b): Unadjusted technique survival by
diabetes status (censored for death & transplant),
1993-2012
Kaplan-Meier survival estimates, by Diabetes
1.00
Non-diabetic
Diabetic
0.75
0.50
0.25
0.00
0
24
48
72
96
120 144
Duration in months
168
192
216
240
Source: 20th MDTR Report 2012, NRR